Development
Medtronic plc
MDT
$87.44
$0.440.51%
NYSE
| 01/26/2024 | 10/27/2023 | 07/28/2023 | 04/28/2023 | 01/27/2023 | |
|---|---|---|---|---|---|
| Revenue | 32.32B | 31.96B | 31.56B | 31.23B | 30.77B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.32B | 31.96B | 31.56B | 31.23B | 30.77B |
| Cost of Revenue | 11.08B | 10.97B | 10.74B | 10.62B | 10.24B |
| Gross Profit | 21.24B | 20.99B | 20.82B | 20.61B | 20.53B |
| SG&A Expenses | 12.05B | 11.98B | 11.91B | 11.86B | 11.78B |
| Depreciation & Amortization | -2.00M | 10.00M | 6.00M | 0.00 | -23.00M |
| Other Operating Expenses | 177.00M | 183.00M | 253.00M | 285.00M | 264.00M |
| Total Operating Expenses | 26.01B | 25.84B | 25.58B | 25.46B | 24.97B |
| Operating Income | 6.31B | 6.12B | 5.98B | 5.77B | 5.81B |
| Income Before Tax | 5.53B | 5.43B | 5.52B | 5.36B | 5.41B |
| Income Tax Expenses | 1.30B | 1.31B | 1.87B | 1.58B | 1.33B |
| Earnings from Continuing Operations | 4.23K | 4.12K | 3.65K | 3.78K | 4.09K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -32.00M | -23.00M | -29.00M | -25.00M | -22.00M |
| Net Income | 4.20B | 4.10B | 3.62B | 3.76B | 4.06B |
| EBIT | 6.31B | 6.12B | 5.98B | 5.77B | 5.81B |
| EBITDA | 8.73B | 8.57B | 8.42B | 8.21B | 8.51B |
| EPS Basic | 3.16 | 3.08 | 2.72 | 2.82 | 3.05 |
| Normalized Basic EPS | 3.11 | 3.02 | 2.99 | 2.90 | 2.83 |
| EPS Diluted | 3.14 | 3.07 | 2.71 | 2.82 | 3.04 |
| Normalized Diluted EPS | 3.10 | 3.02 | 2.99 | 2.89 | 2.82 |
| Average Basic Shares Outstanding | 5.32B | 5.32B | 5.32B | 5.32B | 5.33B |
| Average Diluted Shares Outstanding | 5.33B | 5.33B | 5.33B | 5.33B | 5.34B |
| Dividend Per Share | 2.75 | 2.74 | 2.73 | 2.72 | 2.67 |
| Payout Ratio | 87.07% | 88.88% | 100.33% | 96.25% | 87.47% |